Fefisol II
BIO has granted EUR 350,000 of technical assistance to FEFISOL II, a debt fund focused primarily on sub-Saharan Africa
Amount
€ 350,000.00
Type of investment
Subsidy
Beneficiary locations
Investment field
Investment Companies & Funds
Activity
FEFISOL II, the European Solidarity Financing Fund for Africa II, is a fund that will provide medium to long-term loan financing, essentially in local currency, to African MFIs and agricultural entities, including smallholder producer organisations and small agricultural entities.
Technical assistance facility
The technical assistance facility aims to improve the capacities of Fefisol II investees, their skills and know-how.
The objective is to finance and strengthen the African economic agents underserved by the mainstream banking sector, bringing services and markets to vulnerable and rural populations, as well as small enterprises, particularly those of the agricultural sector to fulfil the objectives of improving living standards, reducing inequalities and achieving sustainable development
Expected impact
- Strengthen access to finance for Africa's underserved private sector
- Strengthen agricultural value chains
- Support the implementation of social and environmental practices
- Support inclusive, customised, and responsible product offerings
- Implement sustainable agricultural practices
- Reduce vulnerabilities to climate change
In order to improve living standards, reduce inequalities and achieve sustainable development
View more of our investments in this region
Investment Companies & Funds
Metier Capital Growth Fund III
6,000,000.00
Ghana, Kenya, Nigeria, South Africa, Uganda
30/06/2023
Infrastructure
Spark + Africa Fund
350,000.00
Burkina Faso, Côte d'Ivoire, Ghana, Kenya, Rwanda, Senegal, Tanzania, Uganda
01/06/2023
Subsidy
Investment Companies & Funds
Agri-Vie Fund II
200,000.00
Kenya, South Africa, Uganda, Zambia
21/03/2023
Subsidy
Investment Companies & Funds
Afrigreen Fund
10,000,000.00
Cameroon, Côte d'Ivoire, Ghana, Mali, Nigeria, Senegal
23/02/2023
Equity